Xenon Pharmaceuticals Inc. Common Shares (XENE) Technical Analysis
$37.01
Insights
- Xenon Pharmaceuticals Inc. is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
- Based on analysis of the Oscillators technical indicator, the current market trend for Xenon Pharmaceuticals Inc. stock suggests that it is a good time to buy
- Based on analysis of the Moving Averages technical indicator, Xenon Pharmaceuticals Inc. stock is in a downtrend↘️
- Based on analysis of the Pivot Points, the current market trend for Xenon Pharmaceuticals Inc. stock suggests that it is a good time to sell or bad time to initiate a fresh position
Analysis Summary
Oscillators
Sell
Neutral
Buy
Moving Averages
Sell
Neutral
Buy
Pivots
Sell
Neutral
Buy
Oscillators
Name | Value | Action |
|---|---|---|
Relative Strength Index | 17.63 | Buy |
Stochastic | 8.12, 4.94 | Buy |
Ultimate Oscillator | 26.72 | Buy |
Stochastic Relative Strength Index | 6.19, 2.31 | Buy |
Moving Average Convergence Divergence | -5.99, -3.7 | Neutral |
Moving Averages
Simple Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 47.97 | Sell |
20 | 53.97 | Sell |
50 | 59.92 | Buy |
Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 45.6 | Sell |
20 | 51.17 | Sell |
50 | 56.53 | Sell |
Volume Weighted Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 42.05 | Sell |
20 | 44.64 | Sell |
50 | 51.34 | Sell |
Double Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 38.34 | Sell |
20 | 43.93 | Sell |
50 | 53.17 | Sell |
Triple Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 35.51 | Sell |
20 | 39.48 | Sell |
50 | 48.6 | Sell |
Pivot
Pivot | Value |
|---|---|
Resistance L3 | 42.13 |
Resistance L2 | 40.82 |
Resistance L1 | 38.69 |
Pivot Point | 37.38 |
Support L1 | 35.25 |
Support L2 | 33.94 |
Support L3 | 31.81 |
*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.